Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience

BACKGROUND/AIMS: The combination of capecitabine and temozolomide (CAPTEM) is one of the treatment options for metastatic pancreatic neuroendocrine neoplasms (pNENs). This study aims to evaluate the efficacy of CAPTEM in patients with metastatic intermediate to high-grade pancreatic neuroendocrine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Douangprachanh, Sathathone, Joo, Hyun Jin, Park, Hyeong Min, Han, Nayoung, Jang, Hye Young, Koh, Young Hwan, Kim, Tae Hyun, Han, Sung-Sik, Park, Sang-Jae, Lee, Woo Jin, Woo, Sang Myung, Chun, Jung Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666252/
https://www.ncbi.nlm.nih.gov/pubmed/36375489
http://dx.doi.org/10.3904/kjim.2022.100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666252/
https://www.ncbi.nlm.nih.gov/pubmed/36375489
http://dx.doi.org/10.3904/kjim.2022.100

Ejemplares similares